Annual Report 10-11 - Elder Pharmaceuticals Ltd.

Recommendations

Info

2010-11,the bigtalking pointsFINANCIAL SNAPSHOTMobilised close to `Raised secured NCDs (Non-Convertiblelong-term resources, including regular`of ``by way of QIPsRaised securedNCDs to augmentmedium to longterm resourcesOPERATIONALSNAPSHOTReceived accreditation from thePatalganga API plant;2010 through the wholly-owned DubaiSubsidiary, Elder International FZCOestablish a footprint in the regulatedEnhanced stake in Biomeda, BulgariaInitiative-Elvista and the Mass MarketInitiative-Adventus;acquisition ofEnhanced stakein Biomeda,Bulgaria to8
Page 2 and 3: COMPANY OVERVIEWNiche is the result
Page 4 and 5: Niche is theresult of innovat vespi
Page 6: Chairman’s MessageDear Shareholde
Page 13 and 14: 28 th Annual Report2010 - 11Company
Page 19 and 20: Annual Report2010 - 11Company Overv
Page 21: 28 th Annual Report2010 - 11Company
Page 24 and 25: Crucial initiatives tostrengthen pr
Page 26 and 27: ManagementDiscussion andAnalysisIND
Page 28 and 29: the industry recorded a 16.5% growt
Page 30: urban. The rural market comprisesap
Page 34 and 35: Pharmaceuticals Ltd.Mr. Edoardo Ric
Page 36 and 37: Pharmaceuticals Ltd.d) That the Dir
Page 38 and 39: Pharmaceuticals Ltd.The company has
Page 40 and 41: Pharmaceuticals Ltd.STATEMENT PURSU
Page 42 and 43: Pharmaceuticals Ltd.BOARD PROCEDURE
Page 44 and 45: Pharmaceuticals Ltd.42No. of Meetin
Page 46 and 47: Pharmaceuticals Ltd.6. DETAILS OF T
Page 48 and 49: Pharmaceuticals Ltd.DISTRIBUTION OF
Page 50 and 51: Pharmaceuticals Ltd.2. Elder Health
Page 52 and 53: Pharmaceuticals Ltd.DeclarationFor
Page 54 and 55: Annexure to the Auditors’ Report.
Page 56 and 57: Balance Sheetas at 31st March 2011S
Page 58 and 59:
Cash Flow Statementfor the year end
Page 60 and 61:
Schedules to Balance Sheetas at 31s
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
year ended 31st March 2011Year Ende
Page 68 and 69:
year ended 31st March 2011Year Ende
Page 70 and 71:
Raw MMix. Foreign currency transact
Page 73 and 74:
28 th Annual Report2010 - 11Company
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Auditors’ ReportOn Consolidated F
Page 81 and 82:
Consolidated Profit & Loss Accountf
Page 83 and 84:
Consolidated Cash Flow Statementfor
Page 85 and 86:
Consolidated Schedules to Balance S
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
year ended 31st March 201128 th Ann
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
International FZCO, Dubai, U.A.E.Di
Page 101 and 102:
International FZCO, Dubai, U.A.E.Ba
Page 103 and 104:
Somerta Holdings Co. Limited (Cypru
Page 105 and 106:
Balance Sheetas at 28 th April 2010
Page 107 and 108:
28 th Annual Report2010 - 11Strateg
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Green InitiativeTo,The Members,Re:
Page 115 and 116:
Notes..............................
Page 119 and 120:
BOARD OF DIRECTORSMR. JAGDISH SAXEN
show all

Annual Report 10-11 - Elder Pharmaceuticals Ltd.

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?